Sanuwave Health Current Ratio 2010-2024 | SNWVD
Sanuwave Health current ratio from 2010 to 2024. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations.
| Sanuwave Health Current Ratio Historical Data |
| Date |
Current Assets |
Current Liabilities |
Current Ratio |
| 2024-06-30 |
$0.01B |
$0.06B |
0.15 |
| 2024-03-31 |
$0.01B |
$0.07B |
0.15 |
| 2023-12-31 |
$0.01B |
$0.07B |
0.15 |
| 2023-09-30 |
$0.01B |
$0.09B |
0.09 |
| 2023-06-30 |
$0.01B |
$0.08B |
0.08 |
| 2023-03-31 |
$0.01B |
$0.07B |
0.06 |
| 2022-12-31 |
$0.01B |
$0.06B |
0.11 |
| 2022-09-30 |
$0.01B |
$0.05B |
0.13 |
| 2022-06-30 |
$0.01B |
$0.05B |
0.10 |
| 2022-03-31 |
$0.00B |
$0.05B |
0.06 |
| 2021-12-31 |
$0.00B |
$0.06B |
0.08 |
| 2021-09-30 |
$0.01B |
$0.05B |
0.10 |
| 2021-06-30 |
$0.01B |
$0.04B |
0.12 |
| 2021-03-31 |
$0.01B |
$0.04B |
0.15 |
| 2020-12-31 |
$0.01B |
$0.04B |
0.22 |
| 2020-09-30 |
$0.01B |
$0.03B |
0.32 |
| 2020-06-30 |
$0.00B |
$0.02B |
0.10 |
| 2020-03-31 |
$0.00B |
$0.01B |
0.17 |
| 2019-12-31 |
$0.00B |
$0.01B |
0.20 |
| 2019-09-30 |
$0.00B |
$0.02B |
0.07 |
| 2019-06-30 |
$0.00B |
$0.02B |
0.06 |
| 2019-03-31 |
$0.00B |
$0.02B |
0.05 |
| 2018-12-31 |
$0.00B |
$0.02B |
0.07 |
| 2018-09-30 |
$0.00B |
$0.01B |
0.05 |
| 2018-06-30 |
$0.00B |
$0.02B |
0.08 |
| 2018-03-31 |
$0.00B |
$0.02B |
0.06 |
| 2017-12-31 |
$0.00B |
$0.01B |
0.11 |
| 2017-09-30 |
$0.00B |
$0.00B |
0.11 |
| 2017-06-30 |
$0.00B |
$0.01B |
0.06 |
| 2017-03-31 |
$0.00B |
$0.00B |
0.30 |
| 2016-12-31 |
$0.00B |
$0.01B |
0.12 |
| 2016-09-30 |
$0.00B |
$0.00B |
0.74 |
| 2016-06-30 |
$0.00B |
$0.00B |
0.36 |
| 2016-03-31 |
$0.00B |
$0.01B |
0.16 |
| 2015-12-31 |
$0.00B |
$0.00B |
0.43 |
| 2015-09-30 |
$0.00B |
$0.00B |
0.86 |
| 2015-06-30 |
$0.00B |
$0.00B |
1.47 |
| 2015-03-31 |
$0.00B |
$0.01B |
0.48 |
| 2014-12-31 |
$0.00B |
$0.01B |
0.65 |
| 2014-09-30 |
$0.01B |
$0.01B |
0.82 |
| 2014-06-30 |
$0.01B |
$0.00B |
6.90 |
| 2014-03-31 |
$0.01B |
$0.00B |
5.21 |
| 2013-12-31 |
$0.00B |
$0.00B |
0.27 |
| 2013-09-30 |
$0.00B |
$0.00B |
0.30 |
| 2013-06-30 |
$0.00B |
$0.01B |
0.06 |
| 2013-03-31 |
$0.00B |
$0.01B |
0.14 |
| 2012-12-31 |
$0.00B |
$0.00B |
0.19 |
| 2012-09-30 |
$0.00B |
$0.00B |
0.39 |
| 2012-06-30 |
$0.00B |
$0.00B |
0.85 |
| 2012-03-31 |
$0.00B |
$0.00B |
1.33 |
| 2011-12-31 |
$0.01B |
$0.00B |
1.97 |
| 2011-09-30 |
$0.01B |
$0.00B |
2.58 |
| 2011-06-30 |
$0.01B |
$0.00B |
3.06 |
| 2011-03-31 |
$0.00B |
$0.01B |
0.39 |
| 2010-12-31 |
$0.00B |
$0.01B |
0.14 |
| 2010-09-30 |
$0.00B |
$0.01B |
0.11 |
| 2010-06-30 |
$0.00B |
$0.01B |
0.23 |
| 2010-03-31 |
$0.00B |
$0.00B |
0.48 |
| 2009-12-31 |
$0.00B |
$0.00B |
0.94 |
| 2009-09-30 |
$0.00B |
$0.00B |
1.59 |
| 2009-06-30 |
$0.00B |
$0.00B |
0.01 |
| 2009-03-31 |
$0.00B |
$0.00B |
0.05 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
MED PRODUCTS |
$0.056B |
$0.020B |
|
SANUWAVE Health, Inc. is engaged in the development and commercialization of non-invasive, biological response-activating devices for the repair and regeneration of tissue, musculoskeletal and vascular structures. The Company's product candidates include its proprietary PACE technology applicable in wound healing, orthopedic/spine, plastic/cosmetic and cardiac conditions; and dermaPACE for treatment of the skin and subcutaneous soft tissue. The Company's products help in activating biologic signaling and angiogenic responses, including new vascularization and microcirculatory improvement, helping to restore the body's normal healing processes and regeneration. SANUWAVE Health, Inc. is based in Alpharetta, USA.
|
